<DOC>
	<DOCNO>NCT02340702</DOCNO>
	<brief_summary>The presence chronic obstructive pulmonary disease ( COPD ) would confer increased in-hospital mortality length hospital stay patient acute decompensated heart failure Assess ( 1 ) prevalence COPD patient hospitalize acute decompensated heart failure ( 2 ) association COPD in-hospital mortality length stay cohort .</brief_summary>
	<brief_title>Chronic Obstructive Pulmonary Disease ( COPD ) Patients Hospitalized Acute Decompensated Heart Failure .</brief_title>
	<detailed_description>Background : The prevalence mild moderate COPD ~5 % -10 % one-year mortality around 3 % heart failure affect is1 % -3 % one year mortality 5-7 % community . The mortality COPD heart failure dramatically increase follow hospitalization . Heart failure COPD independent predictor increase morbidity mortality . COPD heart failure frequently co-exist individual patient share risk factor . The prevalence COPD heart failure patient-population vice verse varies widely accord patient-selection age population . Estimates suggest COPD present 10-40 % patient heart failure . Conversely , unrecognized heart failure identify approximately 20 % patient COPD . The impact COPD clinical outcome patient acute decompensated heart failure unclear . Methods : This observational cohort study . Per national registry , acute heart failure define either new onset heart failure decompensation chronic establish heart failure symptom sufficient warrant hospitalization . The data relate following variable would collect : age , gender , severity heart failure ( mild , moderate , severe prior admission ) , presence dyspnea , peripheral edema , crackle , systolic diastolic blood pressure ( admission discharge ) , heart rate ( admission discharge ) , oxygen saturation ( admission discharge ) , blood urea nitrogen ( admission discharge ) , serum creatinine ( admission discharge ) , serum sodium ( admission discharge ) , hemoglobin ( admission discharge ) , red cell distribution width ( admission discharge ) , electrocardiographic interval ( admission discharge ) , comorbidities ( coronary artery disease , chronic kidney disease , atrial fibrillation , diabetes , hypertension , dyslipidemia , peripheral artery disease , COPD/asthma , leave ventricular ejection fraction &gt; 40 % . Medication use : angiotensin convert enzyme inhibitor , angiotensin receptor blocker , aspirin , metoprolol tartrate , metoprolol succinate , carvedilol , atenolol , amlodipine , Cardizem , clopidogrel , digoxin , diuretic , statin , nitrate , warfarin , non-steroidal anti-inflammatory drug , hydralazine . End-points : 1 ) All cause in-hospital death 2 ) length hospital stay heart failure patient COPD COPD .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Heart failure Ambulatory patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>COPD heart failure</keyword>
</DOC>